The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 334:469-472 February 15, 1996 Number 7
NextNext

Familial Melanoma and Pancreatic Cancer

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Goldstein, A. M.
-PubMed Citation
To the Editor: The studies by Goldstein and Whelan and their colleagues (Oct. 12 issue)1,2 indicate that p16 mutations are required for the development of pancreatic cancer in 10 melanoma-prone kindreds in the United States, Australia, and the Netherlands, which were previously characterized with respect to chromosome 9p21 by linkage analysis. We have found evidence relating the risk of pancreatic adenocarcinoma to a p16 mutation in bloodline members of melanoma-prone Italian families.

So far, within a small geographic area of Italy (possibly because of a founder effect), we have detected the same Gly93Trp mutation in seven apparently unrelated families and . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.